Novo Nordisk | Umlaufvermögen



Current Assets Veränderung Datum
ANI Pharmaceuticals USD 527.68M 6.39M 2024-12
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Bausch Health Companies USD 5.35B 140M 2024-09
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 471.6M 4.62M 2024-12
Drreddys Laboratories INR 253.02B 4.89B 2024-12
Eli Lilly USD 32.74B 1.32B 2024-12
GlaxoSmithKline GBP 17B 301M 2024-12
Merck USD 38.78B 1.58B 2024-12
Novartis USD 29.7B 1.56B 2024-12
Novo Nordisk 195.16B 17.66B 2024-09
Novo Nordisk DKK 195.16B 17.66B 2024-09
Pacira USD 745.13M 55.16M 2024-12
Perrigo USD 2.48B 1.23B 2024-12
Prestige Brands USD 377.16M 3.54M 2024-12
Sanofi 44.02B 1.43B 2025-03
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
Zoetis USD 5.99B 296M 2024-12



Novo Nordisk Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.